Zilia Ocular to Support Study in AMD and DME
Zilia Ocular device will be used in a new 24-month clinical study at the Toronto Retina Institute (TRI). The ThRIVE study will directly compare next-generation anti-VEGF therapies in patients with age-related macular degeneration (AMD) and diabetic macular edema (DME) — two of the leading causes of vision loss worldwide.
Glaucoma Diagnosis and Management: What If We Could Intervene Sooner?
Glaucoma is a multifaceted ocular disease, which involves the degeneration of the optic nerve characterized by retinal ganglion...
One step closer to better ocular health: Zilia secures $4 million in seed funding
Zilia announced today the closing of a $4 million seed funding round led by Anges Québec. In this round, Zilia notably received...
Consequences of Vision Loss and the Importance of Early Diagnosis
The implications of vision loss are far-reaching, impacting individuals, communities, and societies as a whole.The Canadian...
Why the Eye is the Window to Brain Pathology
The eyes may be windows to our soul and psyche, but they are also windows to our health. In embryonic development, the optic...
5 Best Reads in Ocular Oximetry
With all this buzz about ocular oximetry, where can you get more information on the subject? Rather than sifting through...
What Is Ocular Oximetry?
The eye is a marvelous and mysterious organ and we are constantly making discoveries when it comes to its inner workings. As we...
Vascular Dysregulation and Ocular Disease
Nearly 4.2 million Americans aged 40 and older suffer from uncorrectable vision impairment (1). As the population ages, this...
Patrick Sauvageau Elected to Optonique’s Board of Directors
At the third annual general meeting of Optonique, which was held virtually on June 11, Zilia’s CEO, Dr. Patrick Sauvageau, has...
Dr. John G. Flanagan Joins Zilia’s Scientific Advisory Board
Zilia is honored to welcome current Dean and Professor at the University of California Berkeley School of Optometry Dr. John G....
Zilia selected for Microsoft for Startups Program
Zilia is very proud to announce its selection for Microsoft For Startups, a program designed to support the top startup...
Protecting Eye Health During Space Travel
On November 13 and 14, Zilia participated in the National Forum on Space Health organized by the Canadian Space Agency. The...
How Artificial Intelligence is Transforming Ocular Health
Artificial intelligence (AI) applications are bound to revolutionize many industries. Eyecare is no exception, and this is why...
Solutions
